PMID- 26479580 OWN - NLM STAT- MEDLINE DCOM- 20160929 LR - 20220331 IS - 1360-0451 (Electronic) IS - 0954-0121 (Print) IS - 0954-0121 (Linking) VI - 28 IP - 4 DP - 2016 TI - Coronary artery disease risk reduction in HIV-infected persons: a comparative analysis. PG - 475-82 LID - 10.1080/09540121.2015.1099602 [doi] AB - Despite an increased risk of coronary artery disease (CAD) in persons infected with human immunodeficiency virus (HIV), few data are available on primary prevention of CAD in this population. In this retrospective cohort study, HIV-infected patients treated in an academic medical center HIV Specialty Clinic between 1996 and 2010 were matched by age, gender, and ethnicity to a cohort of presumed uninfected persons followed in an academic medical center Internal Medicine primary care clinic. We compared CAD primary prevention care practices between the two clinics, including use of aspirin, HMG-CoA reductase inhibitors ("statins"), and anti-hypertensive drugs. CAD risk between the two groups was assessed with 10-year Framingham CAD risk scores. In the comparative analysis, 890 HIV-infected persons were compared to 807 controls. Ten-year Framingham CAD Risk Scores were similar in the two groups (median, 3; interquartile range [IQR], 0-5). After adjusting for relevant risk factors, HIV-infected persons were less likely to be prescribed aspirin (odds ratio [OR] 0.53; 95% confidence interval [CI], 0.40-0.71), statins (OR, 0.70; 95% CI, 0.53-0.92), and anti-hypertensive drugs (OR, 0.63; 95% CI, 0.50-0.79) than persons in the control group. In summary, when compared to demographically similar uninfected persons, HIV-infected persons treated in an HIV specialty clinic were less likely to be prescribed medications appropriate for CAD risk reduction. Improving primary preventative CAD care in HIV specialty clinic populations is an important step toward diminishing risk of heart disease in HIV-infected persons. FAU - Okeke, Nwora Lance AU - Okeke NL AD - a Division of Infectious Diseases, Department of Medicine , Duke University Medical Center , Durham , NC , USA. FAU - Chin, Tammy AU - Chin T AD - b School of Medicine , The University of North Carolina , Chapel Hill , NC , USA. FAU - Clement, Meredith AU - Clement M AD - a Division of Infectious Diseases, Department of Medicine , Duke University Medical Center , Durham , NC , USA. FAU - Chow, Shein-Chung AU - Chow SC AD - c Department of Biostatistics and Bioinformatics , Duke University School of Medicine , Durham , NC , USA. FAU - Hicks, Charles B AU - Hicks CB AD - d Division of Infectious Diseases, Department of Medicine , University of California , San Diego , CA , USA. LA - eng GR - P30 AI064518/AI/NIAID NIH HHS/United States GR - T32 AI007392/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20151019 PL - England TA - AIDS Care JT - AIDS care JID - 8915313 RN - R16CO5Y76E (Aspirin) SB - IM MH - Adult MH - Aspirin/administration & dosage/*therapeutic use MH - Case-Control Studies MH - Coronary Artery Disease/*prevention & control MH - Drug Prescriptions/*statistics & numerical data MH - Female MH - HIV Infections/*complications/epidemiology MH - Humans MH - Male MH - Middle Aged MH - Odds Ratio MH - *Practice Patterns, Physicians' MH - Retrospective Studies MH - Risk Factors MH - Risk Reduction Behavior PMC - PMC4784685 MID - NIHMS732665 OTO - NOTNLM OT - HIV OT - cardiovascular disease OT - clinical outcomes research OT - coronary artery disease OT - primary care EDAT- 2015/10/20 06:00 MHDA- 2016/09/30 06:00 PMCR- 2016/04/01 CRDT- 2015/10/20 06:00 PHST- 2015/10/20 06:00 [entrez] PHST- 2015/10/20 06:00 [pubmed] PHST- 2016/09/30 06:00 [medline] PHST- 2016/04/01 00:00 [pmc-release] AID - 10.1080/09540121.2015.1099602 [doi] PST - ppublish SO - AIDS Care. 2016;28(4):475-82. doi: 10.1080/09540121.2015.1099602. Epub 2015 Oct 19.